College of Medicine, The Ohio State University, Columbus, Ohio, U.S.A.
Center for Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, U.S.A.
Laryngoscope. 2023 Mar;133(3):512-520. doi: 10.1002/lary.30206. Epub 2022 May 25.
OBJECTIVES/HYPOTHESIS: Partially decellularized tracheal scaffolds have emerged as a potential solution for long-segment tracheal defects. These grafts have exhibited regenerative capacity and the preservation of native mechanical properties resulting from the elimination of all highly immunogenic cell types while sparing weakly immunogenic cartilage. With partial decellularization, new considerations must be made about the viability of preserved chondrocytes. In this study, we propose a multimodal approach for quantifying chondrocyte viability for airway tissue engineering.
Tracheal segments (5 mm) were harvested from C57BL/6 mice, and immediately stored in phosphate-buffered saline at -20°C (PBS-20) or biobanked via cryopreservation. Stored and control (fresh) tracheal grafts were implanted as syngeneic tracheal grafts (STG) for 3 months. STG was scanned with micro-computed tomography (μCT) in vivo. STG subjected to different conditions (fresh, PBS-20, or biobanked) were characterized with live/dead assay, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and von Kossa staining.
Live/dead assay detected higher chondrocyte viability in biobanked conditions compared to PBS-20. TUNEL staining indicated that storage conditions did not alter the proportion of apoptotic cells. Biobanking exhibited a lower calcification area than PBS-20 in 3-month post-implanted grafts. Higher radiographic density (Hounsfield units) measured by μCT correlated with more calcification within the tracheal cartilage.
We propose a strategy to assess chondrocyte viability that integrates with vivo imaging and histologic techniques, leveraging their respective strengths and weaknesses. These techniques will support the rational design of partially decellularized tracheal scaffolds.
N/A Laryngoscope, 133:512-520, 2023.
目的/假设:部分脱细胞气管支架已成为长段气管缺损的一种潜在解决方案。这些移植物具有再生能力,并保留了天然的机械性能,因为所有高度免疫原性的细胞类型都被消除了,而保留了免疫原性较弱的软骨。在部分脱细胞化的情况下,必须对保留的软骨细胞的活力进行新的考虑。在这项研究中,我们提出了一种多模态方法来定量气道组织工程中软骨细胞的活力。
从 C57BL/6 小鼠中采集气管段(5 毫米),并立即储存在 -20°C 的磷酸盐缓冲盐水(PBS-20)中或通过冷冻保存进行生物银行存储。储存和对照(新鲜)气管移植物作为同种异体气管移植物(STG)植入 3 个月。STG 在体内用微计算机断层扫描(μCT)进行扫描。对不同条件(新鲜、PBS-20 或生物银行存储)下的 STG 进行活/死检测、末端脱氧核苷酸转移酶 dUTP 缺口末端标记(TUNEL)和 von Kossa 染色。
活/死检测表明,生物银行存储条件下的软骨细胞活力高于 PBS-20。TUNEL 染色表明,储存条件不会改变凋亡细胞的比例。与 PBS-20 相比,生物银行存储在植入后 3 个月的移植物中表现出较低的钙化面积。μCT 测量的更高的放射密度(Hounsfield 单位)与气管软骨内的更多钙化相关。
我们提出了一种评估软骨细胞活力的策略,该策略结合了体内成像和组织学技术,利用了它们各自的优缺点。这些技术将支持部分脱细胞气管支架的合理设计。
N/A 喉镜,133:512-520,2023。